An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), has developed the drug, in collaboration with Dr Reddy’s Laboratories, Hyderabad.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by day-3 in comparison to SOC, indicating an early relief from oxygen therapy/dependence. The drug comes in the form of a powder in a sachet & is supposed to be dissolved in water.
Important takeaways for all competitive exams:
Weekly Current Affairs One-Liners Current Affairs 2026 plays a very important role in competitive examinations…
On June 21st every year millions of people celebrate International Yoga Day by practicing the…
On 21st June, millions of the people around the world celebrates Father’s Day by expressing…
On 21st June, International Yoga Day observed and it will bring together the millions of…
National News Supreme Court Declares Right to Walk Safely a Fundamental Right The Supreme Court…
India has inducted its first homegrown hovercraft into the Indian Coast Guard. This newly inducted…